Tag: STAT+

January 12, 2026

Alnylam’s Five-Year Plan Amidst Drug Sales Shortfall

January 11, 2026

FDA Delays Expedited Filing for Dravet’s Drug in Stoke Case

January 10, 2026

Merck Deal & J&J Trump Pricing: Pharma Industry News

January 8, 2026

ACA Premium Subsidies Extended: House Vote on Affordability

January 7, 2026

CDC Vaccine Schedule & NIH Funding: DC Diagnosis

January 6, 2026

FDA Relaxes Oversight of AI-Enabled Devices and Wearables

January 4, 2026

Trump’s $50 Billion Rural Health Fund Rewards States with MAHA Ideas

January 3, 2026

Wegovy Pill Price: Novo’s Weight Loss Strategy

January 2, 2026

Healthcare Policy Issues to Watch in 2026

December 30, 2025

EPP Drug Access Concerns: Patients with Sunlight Pain Worry

December 28, 2025

Health AI Deregulation Shifts Burden to Health Systems

December 27, 2025

NIH Director Ousted Amid Neurological Disorders Concerns

December 26, 2025

Brain-Computer Implants: 3 Trends for 2026

December 26, 2025

U.S. Vaccine Policy Changes Expected in 2026

December 23, 2025

Pharma Companies Trump Medicare Price Cuts

December 23, 2025

Trump Moves to Require Lower Drug Prices in Medicare